Applied Therapeutics APLT Stock
Applied Therapeutics Price Chart
Applied Therapeutics APLT Financial and Trading Overview
| Applied Therapeutics stock price | 5.16 USD |
| Previous Close | 1.43 USD |
| Open | 1.42 USD |
| Bid | 0 USD x 1100 |
| Ask | 0 USD x 800 |
| Day's Range | 1.37 - 1.5 USD |
| 52 Week Range | 0.5 - 2.18 USD |
| Volume | 233.47K USD |
| Avg. Volume | 417.24K USD |
| Market Cap | 82.72M USD |
| Beta (5Y Monthly) | 1.901873 |
| PE Ratio (TTM) | N/A |
| EPS (TTM) | -1.42 USD |
| Forward Dividend & Yield | N/A (N/A) |
| Ex-Dividend Date | N/A |
| 1y Target Est | 7.67 USD |
APLT Valuation Measures
| Enterprise Value | 60.58M USD |
| Trailing P/E | N/A |
| Forward P/E | -1.2882882 |
| PEG Ratio (5 yr expected) | N/A |
| Price/Sales (ttm) | 7.7602715 |
| Price/Book (mrq) | N/A |
| Enterprise Value/Revenue | 5.683 |
| Enterprise Value/EBITDA | N/A |
Trading Information
Applied Therapeutics Stock Price History
| Beta (5Y Monthly) | 1.901873 |
| 52-Week Change | 36.19% |
| S&P500 52-Week Change | 20.43% |
| 52 Week High | 2.18 USD |
| 52 Week Low | 0.5 USD |
| 50-Day Moving Average | 1.34 USD |
| 200-Day Moving Average | 1.04 USD |
APLT Share Statistics
| Avg. Volume (3 month) | 417.24K USD |
| Avg. Daily Volume (10-Days) | 228.3K USD |
| Shares Outstanding | 57.85M |
| Float | 30.68M |
| Short Ratio | 2.81 |
| % Held by Insiders | 12.06% |
| % Held by Institutions | 66.18% |
| Shares Short | 880K |
| Short % of Float | 1.93% |
| Short % of Shares Outstanding | 1.52% |
Dividends & Splits
| Trailing Annual Dividend Rate | 0 |
| Trailing Annual Dividend Yield | 0% |
| 5 Year Average Dividend Yield | N/A |
| Payout Ratio | 0 |
| Last Split Factor |
Financial Highlights
Fiscal Year
| Fiscal Year Ends | December 31, 2022 |
| Most Recent Quarter (mrq) | March 31, 2023 |
| Next Fiscal Year End | December 31, 2023 |
Profitability
| Profit Margin | 0% |
| Operating Margin (ttm) | -663.29% |
| Gross Margin | 100.00% |
| EBITDA Margin | 0% |
Management Effectiveness
| Return on Assets (ttm) | -93.078% |
| Return on Equity (ttm) | -366.96% |
Income Statement
| Revenue (ttm) | 10.66M USD |
| Revenue Per Share (ttm) | 0.24 USD |
| Quarterly Revenue Growth (yoy) | N/A |
| Gross Profit (ttm) | N/A |
| EBITDA | N/A |
| Net Income Avi to Common (ttm) | -69524000 USD |
| Diluted EPS (ttm) | -1.5 |
| Quarterly Earnings Growth (yoy) | N/A |
Balance Sheet
| Total Cash (mrq) | 22.92M USD |
| Total Cash Per Share (mrq) | 0.4 USD |
| Total Debt (mrq) | 774K USD |
| Total Debt/Equity (mrq) | N/A |
| Current Ratio (mrq) | 0.874 |
| Book Value Per Share (mrq) | -0.085 |
Cash Flow Statement
| Operating Cash Flow (ttm) | -60673000 USD |
| Levered Free Cash Flow (ttm) | -21831876 USD |
Profile of Applied Therapeutics
| Country | United States |
| State | NY |
| City | New York |
| Address | 545 5th Avenue |
| ZIP | 10017 |
| Phone | 212 220 9226 |
| Website | https://www.appliedtherapeutics.com |
| Industry | Biotechnology |
| Sector(s) | Healthcare |
| Full Time Employees | 26 |
Applied Therapeutics, Inc., a clinical-stage biopharmaceutical company, develops novel products to target central nervous system rare disease and diabetic complications in the United States. Its lead product candidate is AT-007 that has completed phase III for the treatment of galactosemia in healthy volunteers and adults, as well as is in pediatric clinical study for the treatment of galactosemia in kids; for treating sorbitol dehydrogenase deficiency; and for the treatment of phosphomannomutase enzyme-CDG. The company also develops AT-001 that is in phase III clinical trials to treat diabetic cardiomyopathy, as well as for the treatment of diabetic peripheral neuropathy; and AT-003, which is in preclinical studies for the treatment diabetic retinopathy. Applied Therapeutics, Inc. was incorporated in 2016 and is headquartered in New York, New York.
Q&A For Applied Therapeutics Stock
What is a current APLT stock price?
Applied Therapeutics APLT stock price today per share is 5.16 USD.
How to purchase Applied Therapeutics stock?
You can buy APLT shares on the NasdaqGM exchange. Contact your financial advisor to select a broker.
What is the ticker symbol for Applied Therapeutics?
The stock symbol or ticker of Applied Therapeutics is APLT.
Which industry does the Applied Therapeutics company belong to?
The Applied Therapeutics industry is Biotechnology.
How many shares does Applied Therapeutics have in circulation?
The max supply of Applied Therapeutics shares is 105.89M.
What is Applied Therapeutics Price to Earnings Ratio (PE Ratio)?
Applied Therapeutics PE Ratio is now.
What was Applied Therapeutics earnings per share over the trailing 12 months (TTM)?
Applied Therapeutics EPS is -1.42 USD over the trailing 12 months.
Which sector does the Applied Therapeutics company belong to?
The Applied Therapeutics sector is Healthcare.
Applied Therapeutics APLT included in indexes
| Name Name | Price Price |
24h% 7d chart 24h% & 7d |
VOL Volume | 24h low | 24h high | Volume |
|---|
| Name Name | Price Price |
24h% 7d chart 24h% & 7d |
VOL Volume | 24h low | 24h high | Volume | |
|---|---|---|---|---|---|---|---|
| {{ item.name }} {{ item.symbol }} | {{ item.price }} {{ item.price_usd }} |
{{ item.change_pct }}
|
{{ item.volume }} {{ item.volume_usd }} | {{ item.low }} {{ item.low_usd }} | {{ item.high }} {{ item.high_usd }} | {{ item.components_count }} - | {{ item.volume }} {{ item.volume_usd }} |
| NASDAQ Composite IXIC | 16175.09 USD — |
-1.62
|
3.94B USD — | 16125.33 USD — | 16341.46 USD — | — - | 3.94B USD — |
| Stlmt ID NASDAQ Biotechnology NBX | 4604.4 USD — |
-2.98
|
— — | 4555.41 USD — | 4917.8 USD — | — - | — — |
| NASDAQ Global Market Composite NQGM | 2160.36 USD — |
-2.45
|
— — | 2147.48 USD — | 2200.33 USD — | — - | — — |
| NASDAQ Biotechnology NBI | 4195.13 USD — |
-2.14
|
— — | 4174.1 USD — | 4266.29 USD — | — - | — — |
| NASDAQ HealthCare IXHC | 958.68 USD — |
-2.07
|
— — | 954.08 USD — | 972.42 USD — | — - | — — |
- {{ link.label }} {{link}}